Clinical and genomic predictors of brain metastases (BM) in non-small cell lung cancer (NSCLC): An AACR Project GENIE analysis.

被引：3
|
作者：
Rahman, Protiva
LeNoue-Newton, Michele
Chaugai, Sandip
Holt, Marilyn
Jain, Neha M.
Maxwell, Christina
Micheel, Christine
Yang, Yuanchu J.
Ye, Cheng
Schultz, Nikolaus
Riely, Gregory J.
McCarthy, Caroline G.
Rizvi, Hira
Schrag, Deborah
Kehl, Kenneth L.
Lepisto, Eva M.
Yu, Celeste
Bedard, Philippe L.
Fabbri, Daniel
Warner, Jeremy Lyle
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA
[4] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.2032
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2032
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Prognostic Factors Analysis of Non-Small Cell Lung Cancer with Brain Metastases
    Li, J.
    Xue, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2096 - S2096
  • [32] The management of brain metastases in non-small cell lung cancer
    Owen, Scott
    Souhami, Luis
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [33] Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
    Yanjun Xu
    Zhiyu Huang
    Xiaoqing Yu
    Kaiyan Chen
    Yun Fan
    Molecular Brain, 14
  • [34] Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
    Xu, Yanjun
    Huang, Zhiyu
    Yu, Xiaoqing
    Chen, Kaiyan
    Fan, Yun
    MOLECULAR BRAIN, 2021, 14 (01)
  • [35] Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases
    Choi, Ariel R.
    D'Agostino Jr, Ralph B.
    Farris, Michael K.
    Abdulhaleem, Mohammed
    Hunting, John C.
    Wang, Yuezhu
    Smith, Margaret R.
    Ruiz, Jimmy
    Lycan, Thomas W.
    Petty, W. Jeffrey
    Cramer, Christina K.
    Tatter, Stephen B.
    Laxton, Adrian W.
    White, Jaclyn J.
    Li, Wencheng
    Su, Jing
    Whitlow, Christopher
    Xing, Fei
    Chan, Michael D.
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [36] Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
    Tagore, Somnath
    Caprio, Lindsay
    Amin, Amit Dipak
    Bestak, Kresimir
    Luthria, Karan
    D'Souza, Edridge
    Barrera, Irving
    Melms, Johannes C.
    Wu, Sharon
    Abuzaid, Sinan
    Wang, Yiping
    Jakubikova, Viktoria
    Koch, Peter
    Brodtman, D. Zack
    Bawa, Banpreet
    Deshmukh, Sachin K.
    Ebel, Leon
    Ibarra-Arellano, Miguel A.
    Jaiswal, Abhinav
    Gurjao, Carino
    Biermann, Jana
    Shaikh, Neha
    Ramaradj, Priyanka
    Georgis, Yohanna
    Lagos, Galina G.
    Ehrlich, Matthew I.
    Ho, Patricia
    Walsh, Zachary H.
    Rogava, Meri
    Politis, Michelle Garlin
    Biswas, Devanik
    Cottarelli, Azzurra
    Rizvi, Nikhil
    Shu, Catherine A.
    Herzberg, Benjamin
    Anandasabapathy, Niroshana
    Sledge, George
    Zorn, Emmanuel
    Canoll, Peter
    Bruce, Jeffrey N.
    Rizvi, Naiyer A.
    Taylor, Alison M.
    Saqi, Anjali
    Hibshoosh, Hanina
    Schwartz, Gary K.
    Henick, Brian S.
    Chen, Fei
    Schapiro, Denis
    Shah, Parin
    Izar, Benjamin
    NATURE MEDICINE, 2025, : 1351 - 1363
  • [37] A phase II study of abemaciclib in patients (pts) with brain metastases (BM) secondary to non-small cell lung cancer (NSCLC) or melanoma (MEL)
    Sahebjam, S.
    Le Rhun, E.
    Queirolo, P.
    Jerusalem, G.
    Subramaniam, D.
    Bear, M.
    Yang, Z.
    Chen, Y.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [38] Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Valette, C. Audigier
    Mazieres, J.
    Lefebvre, C.
    Le Moulec, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A-M. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer
    Nian, Rui
    Jiang, Huihui
    Zhao, Jiangman
    Hou, Wanle
    Zhang, Hua
    Ma, Jiangtao
    Lv, Pengbiao
    Jiang, Lisha
    Wang, Yongpan
    Xu, Yue
    Wu, Shouxin
    Lou, Jingwei
    Li, Wanjun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 61 (03)
  • [40] Outcome of non-small-cell lung cancer (NSCLC) patients treated for brain metastases (BM) in a single institution
    Chaubet, M.
    Abedallaa, N.
    Le Pechoux, C.
    Planchard, D.
    Soria, J. C.
    Massard, C.
    Besse, B.
    EJC SUPPLEMENTS, 2009, 7 (02): : 521 - 522
12345